Recent trends in breast cancer mortality among White and Black US women

American Journal of Public Health

Volumn 87, Issue 5, 1997, Pages 775-781

  Chevarley, Frances ^a   White, Emily ^b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CAUCASIAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEGRO; UNITED STATES;

EID: 0030999351     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.87.5.775     Document Type: Article

References (32)

1. White E, Urban N, Taylor V. Mammography utilization, public health impact, and cost-effectiveness in the United States, Annu Rev Public Health. 1993;14:605-633.
2. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. Bethesda, MD: National Cancer Institute; 1994. NIH publication 94-2789.
3. Swanson GM, Ragheb NE, Lin C-S, et al. Breast cancer among Black and White women in the 1980's: changing patterns by race, age and extent of disease. Cancer. 1993;72:788-798.
4. White E, Lee CY, Kristal AR. Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst. 1990;82:1546-1555.
5. Day NE, Williams DRR, Khaw KT. Breast cancer screening programmes: the development of monitoring and evaluation system. Br J Cancer. 1989;59:954-958.
6. Early Breast Cancer Trialists' Collaborative Group. Systematic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31 000 recurrences and 27 000 deaths among 75 000 women. Lancet. 1992;339:1-15, 71-85.
7. Kochanek KD, Hudson BL. Advance report of final mortality statistics, 1992. Month Vital Stat Rep. March 22, 1995; 43(6)(suppl).
8. National Center for Health Statistics. Advance report of final mortality statistics, 1991. Month Vital Stat Rep. August 31, 1993;42(2)(suppl).
9. National Center for Statistics. Vital Statistics of the United States, 1990 (and other years). Vol 2. Mortality, part A. Washington, DC: Public Health Service; 1994. DHHS publication PHS 95-1101.
10. Eighth Revision International Classification of Diseases, adapted for use in the United States. National Center for Health Statistics; 1967.
11. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Geneva, Switzerland: World Health Organization; 1977.
12. Klebba AJ, Scott JH. Estimates of selected comparability ratios based on dual coding of 1976 death certificates by the Eighth and Ninth Revisions of the International Classirication of Diseases. Month Vital Stat Rep. February 29, 1980;28(11)(suppl).
13. US population estimates, by age, sex, race, and Hispanic origin: 1980 to 1991. Current Population Reports. P25-1095. Washington, DC: US Bureau of the Census; 1993.
14. Dawson DA, Thompson GB. Breast cancer risk factors and screening: United States, 1987. Vital Health Stat [10] 1990;172. DHHS publication PHS 90-1500.
15. Benson V, Marano MA. Current estimates from the National Health Interview Survey. Vital Health Stat [10] 1994;189. DHHS publication PHS 94-1517.
16. Breslow NE, Day NE. The analysis of case-control studies. In: Statistical Methods in Cancer Research. Lyon, France: International Agency for Research on Cancer, 1980, pp 192-246.
17. Breast cancer death rates decline for White women (News). J Natl Cancer Inst. 1995; 87:173.
18. Quinn M, Allen E, UK Association of Cancer Registries. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. Br Med J. 1995;311:1391-1395.
19. Makuc DM, Freid VM, Kleinman JC. National trends in the use of preventive health care by women. Am J Public Health. 1989;79:21-26.
20. Foster RS, Worden JK, Costanza MC, Solomon LJ. Clinical breast examination and breast self-examination, past and present effect on breast cancer survival. Cancer. April 1992; 69(suppl):1992-1998.
21. Miller BA, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA. 1993;43:27-41.
22. Howard J. Using mammography for cancer control: an unrealized potential. CA. 1987; 37:33-48.
23. Kerlikowske K, Grady D, Rubin S, Sandrock C, Ernster V. Efficacy of screening mammography: a meta-analysis. JAMA. 1995;273:149-154.
24. Tabar L, Fagerberg G, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985;1:829-832.
25. Verbeek ALM, Hendricks JHCL, Holland R, Mravunac M, Sturmans F, Day NE. Reduction of breast cancer mortality through mass screening with modern mammography: first results of the Nijmegen project 1975-81. Lancet. 1984;1:1222-1224.
26. White E. Projected changes in breast cancer incidence due to the trend toward delayed childbearing. Am J Public Health. 1987;77:495-497.
27. Feuer EJ, Wun L-M. How much of the recent rise in breast cancer incidence can be explained by increase in mammography utilization? Am J Epidemiol. 1992;136: 1423-1436.
28. Lantz PM, Remington PL, Newcomb PA. Mammography screening and increased incidence of breast cancer in Wisconsin. J Natl Cancer Inst. 1991;83:1540-1546.
29. Brinton LA, Schairer C. Estrogen replacement therapy and breast cancer risk. Epidemiol Rev. 1993;15:66-79.
30. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332:1589-1593.
31. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White cancer survival study. JAMA. 1994;272:947-954.
32. Wagener DK, Schatzkin A. Temporal trends in the socioeconomic gradient for breast cancer mortality among US women. Am J Public Health. 1994;84:1003-1006.